Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study. - Priyamvada L; Minhaj FS; Likafi T; Pukuta E; Muyamuna E; Carson WC; Moriarty M; Rodriguez S; Joseph T; Kabamba J; Kokola G; Lushima RS; et al. (The Lancet. Infectious diseases, 2026)